Kim Jong Min, Song Phil Hyun, Kim Hyun Tae, Park Tong Choon
Department of Urology, College of Medicine, Yeungnam University, Daegu, Korea.
Korean J Urol. 2010 Sep;51(9):596-600. doi: 10.4111/kju.2010.51.9.596. Epub 2010 Sep 16.
Partial nephrectomy (PN) for patients with T1a renal cell carcinoma (RCC) has increasingly become accepted, although its role for patients with T1b RCC remains controversial. We retrospectively evaluated and then compared the oncologic and functional outcomes of patients with pT1b RCC who were treated with PN or radical nephrectomy (RN).
A total of 70 patients who were diagnosed with pT1bN0M0 RCC between January 1995 and December 2004 were included. The 5-year overall survival (OS), the 5-year recurrence-free survival (RFS), and the 5-year cancer-specific survival (CSS) were compared between the groups. Preoperative and postoperative serum creatinine and estimated glomerular filtration rate (GFR) levels were analyzed to assess renal function.
The 5-year OS (92.3% vs. 87.8%, p=0.501), RFS (92.3% vs. 77.8%, p=0.175), and CSS (92.3% vs. 94.5%, p=0.936) of the PN and RN groups were not statistically different. The proportion of patients with decreased renal function was lower in the PN group than in the RN group (PN=0% vs. RN=11.5%). The postoperative change in serum creatinine and the GFR 1 year after nephrectomy was higher in the RN group than in the PN group (PN=0.2±0.2, 12.1±9.1 vs. RN=0.3±0.5, 18.1±12.5), but there was no statistical difference.
There were no statistically significant differences in prognosis or renal function between patients treated with PN and those treated with RN for pT1b RCC. PN may be a useful treatment modality for patients with pT1b RCC.
对于T1a期肾细胞癌(RCC)患者,部分肾切除术(PN)已越来越被认可,但其对于T1b期RCC患者的作用仍存在争议。我们进行了回顾性评估,然后比较接受PN或根治性肾切除术(RN)治疗的pT1b期RCC患者的肿瘤学和功能结局。
纳入1995年1月至2004年12月期间共70例被诊断为pT1bN0M0期RCC的患者。比较两组患者的5年总生存率(OS)、5年无复发生存率(RFS)和5年癌症特异性生存率(CSS)。分析术前和术后血清肌酐及估计肾小球滤过率(GFR)水平以评估肾功能。
PN组和RN组的5年OS(92.3%对87.8%,p = 0.501)、RFS(92.3%对77.8%,p = 0.175)和CSS(92.3%对94.5%,p = 0.936)无统计学差异。PN组肾功能下降的患者比例低于RN组(PN = 0%对RN = 11.5%)。肾切除术后1年,RN组血清肌酐和GFR的术后变化高于PN组(PN = 0.2±0.2,12.1±9.1对RN = 0.3±0.5,18.1±12.5),但无统计学差异。
对于pT1b期RCC患者,接受PN治疗和接受RN治疗的患者在预后或肾功能方面无统计学显著差异。PN可能是pT1b期RCC患者的一种有效治疗方式。